TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from OneSource Specialty Pharma Limited ( (IN:ONESOURCE) ) is now available.
OneSource Specialty Pharma Limited held its 18th Annual General Meeting, the first since its listing, on September 22, 2025, via video conferencing. The meeting was conducted in compliance with relevant regulations, and Bharat Shah was elected as the Chairperson in the absence of the usual chair and other directors. The AGM highlighted the participation of key board members and management, underscoring the company’s commitment to transparency and stakeholder engagement.
More about OneSource Specialty Pharma Limited
OneSource Specialty Pharma Limited, formerly known as Stelis Biopharma Limited, operates in the pharmaceutical industry. The company focuses on providing specialized pharmaceutical services and products, with a market focus on innovative drug delivery solutions.
Average Trading Volume: 5,125
Technical Sentiment Signal: Hold
Current Market Cap: 210.3B INR
See more data about ONESOURCE stock on TipRanks’ Stock Analysis page.